Cart
sales@molnova.com
Thymocartin
CAS No. 85466-18-8
Thymocartin( —— )
Catalog No. M34720 CAS No. 85466-18-8
Thymocartin (RGH 0206) is a fragment 32-35 of the naturally occurring thymic factor (thymopoietin).Thymocartin is used in the study of immunodeficiency diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 719 | In Stock |
|
| 10MG | 1007 | In Stock |
|
| 25MG | 1501 | In Stock |
|
| 50MG | 1981 | In Stock |
|
| 100MG | 2669 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThymocartin
-
NoteResearch use only, not for human use.
-
Brief DescriptionThymocartin (RGH 0206) is a fragment 32-35 of the naturally occurring thymic factor (thymopoietin).Thymocartin is used in the study of immunodeficiency diseases.
-
DescriptionThymocartin (Thymopoietin II (32-35)) is the 32-35 fragment of the thymic factor (thymopoietin). Thymocartin has shown potential for immunodeficiency diseases research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number85466-18-8
-
Formula Weight516.59
-
Molecular FormulaC21H40N8O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](C(N[C@@H]([C@H](C)C)C(O)=O)=O)(NC([C@@H](NC([C@H](CCCNC(=N)N)N)=O)CCCCN)=O)CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. S Lang, et al. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol. 1996 Nov;48(11):1190-6.?
molnova catalog
related products
-
Riociguat
Riociguat is a stimulator of guanylate cyclase which causes relaxation of vascular smooth muscle and is used to treat severe pulmonary arterial hypertension.
-
4-O-Methylochnaflavo...
4'-O-Methylochnaflavone is a biflavonoid isolated from Lonicera japonica, suppresses mouse lymphocyte proliferation.
-
Ladiratuzumab
LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.
